Explore the innovative biotechnology strategies that are improving processes in biological industries around the world. Over the course of five days, you’ll acquire the tools and frameworks you need to enhance your organization’s downstream process—and drive increased value. Through highly interactive lectures and activities, you’ll examine traditional unit operations, as well as new concepts and emerging technologies, which offer benefits to biochemical product recovery.
Transform your organization's engineering capabilities with comprehensive AI implementation spanning the complete design-to-deployment pipeline, from LLM-driven parametric design through advanced manufacturing optimization, computer vision quality control, and real-world deployment strategies. In this intensive hands-on course, you'll join accomplished global peers to master deployable AI workflows, create neural surrogates for expensive simulations, implement MLOps practices with regulatory compliance, and build complete integrated systems using open-source tools – leaving with working template libraries and custom components ready for immediate organizational deployment.
Brian Anthony
Lead Instructor
Participating Instructor
Brian Anthony is the co-director of MIT’s Medical Electronic Device Realization Center and associate director of MIT.nano. With over 25 years of experience in product realization, Brian Anthony designs instruments and techniques to monitor and control physical systems. His work involves systems analysis and design, calling upon mechanical, electrical, and optical engineering, along with computer science and optimization.
Morris Z. Rosenberg
Dr. Morris Rosenberg is founder and a consultant at MRosenberg BioPharma Consulting. He has over 25 years experience in the development of therapeutic agents to treat a variety of human diseases.
J. Christopher Love
J. Christopher Love is the Raymond A. (1921) and Helen E. St. Laurent Professor of Chemical Engineering. He is also an Associate Member of the Broad Institute, and an Associate Member at the Ragon Institute of MGH, MIT, and Harvard. Following completion of his doctoral studies, he extended his research into immunology at Harvard Medical School with Hidde Ploegh from 2004-2005, and at the Immune Disease Institute from 2005-2007.
James C. Leung
Dr. James C. Leung is a Senior Research Fellow at the MIT Center for Biomedical Innovation (CBI).
Robert D. Kiss
Dr. Robert D. Kiss is a Distinguished Engineer and Senior Director of BioProcess Development at Genentech. His areas of focus within the industry have included media/process optimization and product quality control (especially protein glycosylation), barriers to virus contamination of mammalian cultures, and scale-up/scale-down strategies.
Neal Connors
Dr. Neal Connors is the founder and a consultant at Phoenix BioConsulting, LLC. His industrial microbiology experience is diverse: bioprocess development for renewable chemicals, fermentation and strain improvement for the production of anti-bacterial and anti-fungal natural products (e.g. Cancidas®), heterologous protein production using microbial fermentation or mammalian cell culture, whole-cell biocatalysis for the production of chiral intermediates.
Kristala L. Jones Prather
Kristala Jones Prather is the Arthur D. Little Professor of Chemical Engineering at MIT and an investigator in the multi-institutional Synthetic Biology Engineering Research Center (SynBERC) funded by the National Science Foundation (USA). Professor Prather has co-authored more than 75 manuscripts and two book chapters, and has five issued patents with several additional applications pending.
Daniel I. C. Wang
Director Emeritus Daniel I.C. Wang was the Institute Professor of Chemical Engineering at MIT. He was the recipient of numerous awards from the American Chemical Society, the American Institute of Chemical Engineers, and from schools here and abroad.